These observations suggest that the method utilized in determining ERG status, the inclusion or exclusion of other genomic aberration, and the cohort chosen may be the reason for the different results obtained in various studies investigating the role of ERG in prostate cancer. This evidence concerns the gene ERG and prostate cancer.